BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15221349)

  • 1. The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis.
    Gross CM; Krämer J; Pfeufer A; Dietz R; Gessner R; Praus M
    Basic Res Cardiol; 2004 Jul; 99(4):309-14. PubMed ID: 15221349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
    van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
    Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents.
    Tiroch K; Koch W; Mehilli J; Bottiger C; Schomig A; Kastrati A
    Cardiology; 2009; 112(4):263-9. PubMed ID: 18758183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-alpha polymorphisms and angiographic outcome after coronary artery stenting.
    Ferrero V; Ribichini F; Matullo G; Guarrera S; Carturan S; Vado A; Vassanelli C; Piazza A; Uslenghi E; Wijns W
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2223-8. PubMed ID: 14563649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.
    Völzke H; Kleine V; Robinson DM; Grimm R; Hertwig S; Schwahn C; Eckel L; Rettig R
    Int J Cardiol; 2005 Jan; 98(1):133-9. PubMed ID: 15676177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation.
    Bonta PI; Pols TW; van Tiel CM; Vos M; Arkenbout EK; Rohlena J; Koch KT; de Maat MP; Tanck MW; de Winter RJ; Pannekoek H; Biessen EA; Bot I; de Vries CJ
    Circulation; 2010 May; 121(18):2023-32. PubMed ID: 20421523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial.
    Ribichini F; Ferrero V; Piessens M; Heyndrickx GR; de Bruyne B; Verbeke L; Matullo G; Büchi M; Piazza A; Guarrera S; Lüscher TF; Wijns W
    Cardiovasc Revasc Med; 2005; 6(1):7-13. PubMed ID: 16263350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting.
    Shimada K; Miyauchi K; Mokuno H; Watanabe Y; Iwama Y; Shigekiyo M; Matsumoto M; Okazaki S; Tanimoto K; Kurata T; Sato H; Daida H
    Int J Cardiol; 2004 Mar; 94(1):87-92. PubMed ID: 14996480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease.
    Cattaruzza M; Guzik TJ; Słodowski W; Pelvan A; Becker J; Halle M; Buchwald AB; Channon KM; Hecker M
    Circ Res; 2004 Oct; 95(8):841-7. PubMed ID: 15375006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.
    Vogiatzi K; Voudris V; Apostolakis S; Kochiadakis GE; Thomopoulou S; Zaravinos A; Spandidos DA
    Thromb Res; 2009 May; 124(1):84-9. PubMed ID: 19201454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.
    Chung SL; Chiou KR; Charng MJ
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):349-55. PubMed ID: 16489563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the Pl(A2)allele of the platelet glycoprotein IIIa gene.
    Walter DH; Schächinger V; Elsner M; Mach S; Dimmeler S; Auch-Schwelk W; Zeiher AM
    Eur Heart J; 2001 Apr; 22(7):587-95. PubMed ID: 11259146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.
    Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G
    Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association found between the insertion/deletion of a 287-bp alu repeat sequence within intron 16 of the angiotensin-I-converting enzyme (ACE) gene in Mexican patients and binary restenosis after coronary stenting.
    Martínez-Ríos MA; Peña-Duque MA; Fragoso JM; Delgadillo-Rodríguez H; Pérez-Hernández N; Miranda-Malpica E; Rodríguez-Pérez JM; González-Quesada C; Vargas-Alarcón G
    Clin Chim Acta; 2008 Nov; 397(1-2):65-7. PubMed ID: 18706898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease.
    Schober A; Hoffmann R; Oprée N; Knarren S; Iofina E; Hutschenreuter G; Hanrath P; Weber C
    Am J Cardiol; 2005 Oct; 96(8):1116-22. PubMed ID: 16214449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation.
    Schmitt JF; Keogh MC; Dennehy U; Chen D; Lupu F; Weston K; Taylor D; Kakkar VV; Lemoine NR
    Gene Ther; 1999 Jun; 6(6):1184-91. PubMed ID: 10455424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.
    Shim CY; Park S; Yoon SJ; Park HY; Kim HT; Oh B; Park C; Ko YG; Choi D; Jang Y; Chung N
    Cardiology; 2007; 107(4):261-8. PubMed ID: 16954682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of OAZ1 gene polymorphisms with subclinical and clinical vascular events.
    Dumont J; Zureik M; Bauters C; Grupposo MC; Cottel D; Montaye M; Hamon M; Ducimetière P; Amouyel P; Brousseau T
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2120-6. PubMed ID: 17761941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.